Research and development
Flow – sum over the period · $M
Q3 2023
20.6$M
All values (14)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 135.9 | reported |
| Q1 2026 | 125.6 | reported |
| Q4 2025 | 93.8 | derived |
| Q3 2025 | 78.9 | reported |
| Q2 2025 | 66.7 | reported |
| Q1 2025 | 64.6 | reported |
| Q4 2024 | 56.5 | derived |
| Q3 2024 | 50.7 | reported |
| Q2 2024 | 40.1 | reported |
| Q1 2024 | 53.6 | reported |
| Q4 2023 | 19.7 | derived |
| Q3 2023 | 20.6 | reported |
| Q2 2023 | 17.9 | reported |
| Q1 2023 | 15.3 | reported |
28 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $21.0M
- Period
- Q3 2023, ended Sep 30, 2023 · quarterly value (3 months, not cumulative)
- Source
- 10-Q, filed Nov 5, 2024 · 0001736297-24-000043
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $21.0M | Nov 5, 2024 | 10-Q 0001736297-24-000043 | reported · confidence 1. · current |